[Chinese expert consensus on antithrombotic therapy of panvascular diseases (2024 edition)].

抗血栓 疾病 医学 协商一致会议 冠状动脉疾病 重症监护医学 物理疗法 内科学
出处
期刊:PubMed 卷期号:104 (12): 906-923 被引量:1
标识
DOI:10.3760/cma.j.cn112137-20231101-00959
摘要

Panvascular disease is a systemic condition with vascular lesions (95% of which are atherosclerosis) as the common pathological feature, which can be manifested as coronary artery disease, cerebrovascular disease, peripheral artery disease, etc., or a combination of two or more vascular bed diseases that is called multivascular disease. The burden of panvascular diseases in China is heavy, and improvement of patient prognosis is urgently needed. Although the management of panvascular diseases belongs to different disciplines, they often share common risk factors and pathophysiological mechanisms that warrant standardized treatment strategies. Antithrombotic therapy for panvascular diseases mainly includes antiplatelet and anticoagulant therapy. For patients with different ischemic and bleeding risks and different stages of the disease, there is currently a lack of unified guidance from various disciplines. Given the crucial role of standardized antithrombotic therapy in the treatment of panvascular disease, Chinese College of Cardiovascular Physicians led the organization of a consensus working group consisting of 33 senior experts in the fields of cardiology, vascular surgery, neurology, and endocrinology. "Chinese expert consensus on antithrombotic therapy of panvascular diseases (2024 edition)" was developed based on specific treatment needs of panvascular diseases in China, combined with published clinical research evidence, specialized guidelines and consensus, as well as the recommendations from the consensus expert group. The primary objective of this consensus is to standardize the application of antithrombotic therapy in panvascular diseases, thereby optimizing clinical outcomes, improving patients prognosis, and mitigating the economic and societal burden associated with panvascular disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Tin完成签到,获得积分10
刚刚
yule完成签到 ,获得积分10
4秒前
overThat完成签到,获得积分10
4秒前
8y24dp发布了新的文献求助10
5秒前
HHHH发布了新的文献求助10
5秒前
最好完成签到,获得积分10
6秒前
bliyaa完成签到,获得积分10
7秒前
从容映易完成签到,获得积分10
10秒前
老白完成签到,获得积分10
11秒前
khaosyi完成签到 ,获得积分10
12秒前
qianci2009完成签到,获得积分10
12秒前
zyy完成签到,获得积分10
12秒前
杜鹃发布了新的文献求助10
12秒前
朴实的觅翠完成签到,获得积分10
14秒前
周全完成签到 ,获得积分10
16秒前
学习发布了新的文献求助20
16秒前
小郗完成签到 ,获得积分10
17秒前
笨笨烨华完成签到 ,获得积分10
17秒前
不辞完成签到 ,获得积分10
18秒前
Jasper应助杜鹃采纳,获得10
19秒前
21秒前
GealAntS完成签到,获得积分0
22秒前
熊boy完成签到,获得积分10
22秒前
崩溃完成签到,获得积分10
22秒前
alixy完成签到,获得积分10
23秒前
祭途完成签到,获得积分10
24秒前
研友_VZG7GZ应助junzpeng采纳,获得10
27秒前
phil完成签到,获得积分10
30秒前
老实的石头完成签到,获得积分10
30秒前
球球昂完成签到,获得积分10
30秒前
54完成签到,获得积分10
32秒前
笑点低的元枫完成签到 ,获得积分10
32秒前
turui完成签到 ,获得积分10
35秒前
NiNi完成签到,获得积分10
37秒前
hongt05完成签到 ,获得积分10
39秒前
mmiww完成签到,获得积分10
42秒前
爱听歌的谷蓝完成签到 ,获得积分10
44秒前
领导范儿应助YC采纳,获得30
46秒前
奶油泡fu完成签到 ,获得积分10
47秒前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052675
求助须知:如何正确求助?哪些是违规求助? 2709926
关于积分的说明 7418483
捐赠科研通 2354527
什么是DOI,文献DOI怎么找? 1246159
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921